tripelennamine has been researched along with Syncope in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
KING, G | 1 |
WEEKS, SD | 1 |
Schacher, V | 1 |
Iranpour, B | 1 |
Mills, J | 1 |
1 trial available for tripelennamine and Syncope
Article | Year |
---|---|
The local anesthetic efficacy of tripelennamine hydrochloride.
Topics: Anesthesia, Dental; Anesthesia, Local; Animals; Clinical Trials as Topic; Dental Cavity Preparation; | 1967 |
1 other study available for tripelennamine and Syncope
Article | Year |
---|---|
PYRIBENZAMINE ACTIVATION OF THE ELECTROENCEPHALOGRAM.
Topics: Adolescent; Electroencephalography; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, | 1965 |